Search
for
Sort by
Research 271–300 of 434
- The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls
- The Skin Microbiome: Current Landscape and Future Opportunities
- Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Post-COVID-19 Syndrome Mechanisms, Prevention and Management
- HEALTH SURVEY OF BOREAL CARIBOU (RANGIFER TARANDUS CARIBOU) IN NORTHEASTERN BRITISH COLUMBIA, CANADA
- Stem Cell Therapies for Epidermolysis Bullosa Treatment
- Laser-Assisted Drug Delivery: A Systematic Review of Safety and Adverse Events
- ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review)
- The Protective and Regenerative Potential of Lactoferrin in Hair and Skin Health
- Dynamic remodeling of skin microbiota during healthy homeostatic and wound repair conditions
- Enterococcus faecium secreted the NlpC/P60 family protein to enhance host immunity and indirectly increases Akkermansia muciniphila for slowing aging
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury
- The Multisystem Impact of Long COVID: A Comprehensive Review
- Larvicidal potential, antimicrobial properties and molecular docking analysis of Egyptian Mint (Mentha rotundifolia) against Culex pipiens L. (Diptera: Culicidae) and Midgut-borne Staphylococcus aureus
- The JAK/STAT signaling pathway: from bench to clinic
- JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- 18β‐Glycyrrhetinic acid: its core biological properties and dermatological applications
- New and Emerging Therapies for Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease
- Poster Presentations
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- A Comprehensive Review of Acne Vulgaris
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Research Relevant Conditions and Pathology in Nonhuman Primates
- Advances in Microengineered Platforms for Skin Research